Lazard Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
|
|||||
|
2025
Q1 | $1.46M | Buy |
|
|||||
|
2024
Q4 | $1.21M | Buy |
|
|||||
|
2024
Q3 | $730K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $66K | Sell |
|
|||||
|
2023
Q4 | $84K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $29K | Hold |
|
|||||
|
2022
Q4 | $40K | Hold |
|
|||||
|
2022
Q3 | $44K | Hold |
|
|||||
|
2022
Q2 | $37K | Hold |
|
|||||
|
2022
Q1 | $57K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $46K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $35K | Buy |
|